These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


155 related items for PubMed ID: 9350683

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pathogenesis of parathyroid hyperplasia in renal failure.
    Cozzolino M, Brancaccio D, Gallieni M, Galassi A, Slatopolsky E, Dusso A.
    J Nephrol; 2005; 18(1):5-8. PubMed ID: 15772917
    [Abstract] [Full Text] [Related]

  • 5. Parathyroid growth and suppression in renal failure.
    Lewin E, Huan J, Olgaard K.
    Semin Dial; 2006; 19(3):238-45. PubMed ID: 16689976
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. 1,25-Dihydroxyvitamin D downregulation of TGFalpha/EGFR expression and growth signaling: a mechanism for the antiproliferative actions of the sterol in parathyroid hyperplasia of renal failure.
    Dusso A, Cozzolino M, Lu Y, Sato T, Slatopolsky E.
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):507-11. PubMed ID: 15225829
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hypercalcemic hyperparathyroidism following renal transplantation: differential diagnosis, management, and implications for cell population control in the parathyroid gland.
    Parfitt AM.
    Miner Electrolyte Metab; 1982 Aug; 8(2):92-112. PubMed ID: 6762496
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Molecular basis for the management of secondary hyperparathyroidism in chronic renal failure.
    Fukagawa M, Yi H, Fukuda N, Kurokawa K.
    Artif Organs; 1995 Dec; 19(12):1210-4. PubMed ID: 8967876
    [Abstract] [Full Text] [Related]

  • 14. [The parathyroids and calcitonin. Study of its clinical physiology. II. Thyrocalcitonin and vitamin D; metabolic actions; study of its physiopathology].
    Garrido B, Jiménez JA, Damiano A, Betancort P, Macías A.
    Rev Iber Endocrinol; 1971 Dec; 18(103):49-82. PubMed ID: 4931027
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Vitamin D in normal and pathological parathyroid glands: new prospects for treating hyperparathyroidism (review).
    Buchwald PC, Westin G, Akerström G.
    Int J Mol Med; 2005 Apr; 15(4):701-6. PubMed ID: 15754035
    [Abstract] [Full Text] [Related]

  • 20. Parathyroid autografts--morphology and function: six years' experience with parathyroid autotransplantation in uremic patients.
    Klempa I, Frei U, Röttger P, Schneider M, Koch KM.
    World J Surg; 1984 Aug; 8(4):540-4. PubMed ID: 6485351
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.